CPAs obtained from individuals with ALS include products of translation of ALS risk genes such as FUS and SOD1 (Table 1) and a large number of proteins implicated in the proteasome system, an essential clearance mechanism of defective proteins.59 The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.